Omada Health, Inc. OMDA
18.95 USD -0.48 (-2.47%)
At closeNov 6, 2026, 5:20 AM EST
16.70 -2.25 -11.87%
Pre-market · Nov 6, 5:20 AM ET
18.15 Day range 19.52
10.28 52-week range 25.45
- YTD
- +20.09%
- 1 year
- -13.35%
News
benzinga.com Omada Health Q3 2026 Earnings Call Transcript Omada Health (NASDAQ:OMDA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Omada Health Raises FY2026 Sales Guidance from $334.000M-$340.000M to $344.000M-$346.000M vs $338.537M Est Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $334.000 million-$340.000 million to $344.000 million-$346.000 million vs $338.537 million estimate.
benzinga.com Omada Health Q3 EPS $0.10 Beats $0.02 Estimate, Sales $91.000M Beat $85.676M Estimate Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.02 by 400 percent. This is a 600 percent increase over losses of $(0.02) per…- benzinga.com Barclays Maintains Overweight on Omada Health, Lowers Price Target to $24 Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $27 to $24.
benzinga.com Omada Health To Present Published Research Showing That Members Of Its GLP-1 Care Track Lost More Weight And Experienced Greater Improvements In Body Composition Than GLP-1 Users Receiving Usual Care GLP-1 medications can produce rapid weight loss,2 but lean mass can account for 30% or more of the weight lost.3,4 Lean mass is critical for overall health, as losing lean mass may contribute to…
benzinga.com Transcript: Omada Health Q2 2026 Earnings Conference Call Omada Health (NASDAQ:OMDA) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by…